PT3115365T - Novo sal de composto pirimidina fundido e cristal do mesmo - Google Patents
Novo sal de composto pirimidina fundido e cristal do mesmoInfo
- Publication number
- PT3115365T PT3115365T PT167435577T PT16743557T PT3115365T PT 3115365 T PT3115365 T PT 3115365T PT 167435577 T PT167435577 T PT 167435577T PT 16743557 T PT16743557 T PT 16743557T PT 3115365 T PT3115365 T PT 3115365T
- Authority
- PT
- Portugal
- Prior art keywords
- crystal
- pyrimidine compound
- fused pyrimidine
- novel salt
- fused
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015017387 | 2015-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3115365T true PT3115365T (pt) | 2018-05-07 |
Family
ID=56543556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT167435577T PT3115365T (pt) | 2015-01-30 | 2016-01-29 | Novo sal de composto pirimidina fundido e cristal do mesmo |
Country Status (20)
Country | Link |
---|---|
US (2) | US9908889B2 (pt) |
EP (1) | EP3115365B1 (pt) |
JP (1) | JP6093486B2 (pt) |
KR (1) | KR101852738B1 (pt) |
CN (1) | CN107207517B (pt) |
AU (1) | AU2016213031B2 (pt) |
BR (1) | BR112017016318B1 (pt) |
CA (1) | CA2974335C (pt) |
DK (1) | DK3115365T3 (pt) |
ES (1) | ES2667247T3 (pt) |
HU (1) | HUE038041T2 (pt) |
MX (1) | MX2017009864A (pt) |
MY (1) | MY196997A (pt) |
PH (1) | PH12017501335A1 (pt) |
PL (1) | PL3115365T3 (pt) |
PT (1) | PT3115365T (pt) |
RU (1) | RU2702660C2 (pt) |
SG (1) | SG11201704431VA (pt) |
TW (1) | TWI605049B (pt) |
WO (1) | WO2016121954A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021125313A1 (ja) | 2019-12-19 | 2021-06-24 | 大鵬薬品工業株式会社 | 縮合ピリミジン化合物を有効成分とする治療剤 |
TW202216717A (zh) * | 2020-07-15 | 2022-05-01 | 日商大鵬藥品工業股份有限公司 | 嘧啶化合物之結晶 |
WO2023232958A1 (en) * | 2022-06-01 | 2023-12-07 | Alk-Abelló A/S | Bruton's kinase inhibitors for the treatment of a sudden allergic reaction |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2180223T3 (es) * | 1997-12-01 | 2003-02-01 | Eisu Innovative Ges Fur Techni | Biosorbentes y procedimiento para su produccion. |
US8450335B2 (en) | 2008-06-27 | 2013-05-28 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
US8338439B2 (en) | 2008-06-27 | 2012-12-25 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
TWI662963B (zh) * | 2012-06-04 | 2019-06-21 | 美商製藥有限責任公司 | 布魯頓氏酪胺酸激酶抑制劑之結晶形式 |
US8957080B2 (en) * | 2013-04-09 | 2015-02-17 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
WO2015022926A1 (ja) * | 2013-08-12 | 2015-02-19 | 大鵬薬品工業株式会社 | 新規な縮合ピリミジン化合物又はその塩 |
PL3120852T3 (pl) * | 2015-01-30 | 2019-09-30 | Taiho Pharmaceutical Co., Ltd. | Środek zapobiegawczy i/lub terapeutyczny przeciwko chorobom immunologicznym |
-
2016
- 2016-01-29 BR BR112017016318-7A patent/BR112017016318B1/pt active IP Right Grant
- 2016-01-29 TW TW105102954A patent/TWI605049B/zh active
- 2016-01-29 MX MX2017009864A patent/MX2017009864A/es active IP Right Grant
- 2016-01-29 KR KR1020177018432A patent/KR101852738B1/ko active IP Right Grant
- 2016-01-29 RU RU2017127128A patent/RU2702660C2/ru active
- 2016-01-29 ES ES16743557.7T patent/ES2667247T3/es active Active
- 2016-01-29 EP EP16743557.7A patent/EP3115365B1/en active Active
- 2016-01-29 HU HUE16743557A patent/HUE038041T2/hu unknown
- 2016-01-29 CN CN201680007403.6A patent/CN107207517B/zh active Active
- 2016-01-29 MY MYPI2017701806A patent/MY196997A/en unknown
- 2016-01-29 PT PT167435577T patent/PT3115365T/pt unknown
- 2016-01-29 DK DK16743557.7T patent/DK3115365T3/en active
- 2016-01-29 CA CA2974335A patent/CA2974335C/en active Active
- 2016-01-29 AU AU2016213031A patent/AU2016213031B2/en active Active
- 2016-01-29 SG SG11201704431VA patent/SG11201704431VA/en unknown
- 2016-01-29 JP JP2016533749A patent/JP6093486B2/ja active Active
- 2016-01-29 PL PL16743557T patent/PL3115365T3/pl unknown
- 2016-01-29 WO PCT/JP2016/052733 patent/WO2016121954A1/ja active Application Filing
- 2016-10-19 US US15/297,180 patent/US9908889B2/en active Active
-
2017
- 2017-07-24 PH PH12017501335A patent/PH12017501335A1/en unknown
-
2018
- 2018-01-04 US US15/861,947 patent/US10280174B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL257306B (en) | A compressed pyrimidine compound or a salt thereof | |
GB2542881B (en) | Crystal forms of ß-nicotinamide mononucleotide | |
HK1245770A1 (zh) | 尿嘧啶化合物的新型結晶 | |
HK1217703A1 (zh) | 新型稠合嘧啶化合物或其鹽 | |
HK1247196A1 (zh) | Scy-078的新型鹽及多晶型物 | |
GB2560109B (en) | Thieno pyrimidine compounds and manufacture of the same | |
SG11201704431VA (en) | Novel salt of fused pyrimidine compound and crystal thereof | |
ZA201704795B (en) | Novel crystal forms of the monosodium salt of foramsulfuron | |
EP3505516A4 (en) | QUINAZOLINE DERIVATIVE SALT CRYSTAL | |
RS61238B1 (sr) | Kristal jedinjenja sa inhibitornom aktivnošću prema jak | |
HK1247921A1 (zh) | 哌嗪化合物的新晶體 | |
PT3395819T (pt) | Forma cristalina de derivado de aminopirano substituído | |
ZA201901155B (en) | Salt and crystal of diaza-benzofluorane compound | |
HUP1600613A2 (en) | Crystalline forms of sacubitril hemicalcium salt | |
ZA201603748B (en) | Direct reduction of diamminedichloropalladium (ii) salt | |
GB201519795D0 (en) | Construction of surfaces |